An interesting method of exosomal PD-L1 expression inhibition and its application was investigated by Zhu et al. Researchers constructed a tumor specific nanomodulator containing amlodipine—a calcium channel blocker and GW4869—a neutral sphingomyelinase (nSMase) inhibitor [76]. This evidence concerns the gene SMPD2 and neoplasm.